Gabrilovich D.I. 2017. Myeloid-derived suppressor cells. Cancer Immunol. Res. 5 (1), 3–8. https://doi.org/10.1158/2326-6066.CIR-16-0297

Article  CAS  PubMed  Google Scholar 

Köstlin N., Hofstädter K., Ostermeir A.L., Spring B., Leiber A., Haen S., Abele H., Bauer P., Pollheimer J., Hartl D., Poets C.F., Gille C. 2016. Granulocytic myeloid-derived suppressor cells accumulate in human placenta and polarize toward a Th2 phenotype. J. Immunol. 196 (3), 1132–1145. https://doi.org/10.4049/jimmunol.1501783

Article  CAS  PubMed  Google Scholar 

Ostrand-Rosenberg S., Sinha P., Figley C., Long R., Park D., Carter D., Clements V.K. 2017. Frontline Science: Myeloid-derived suppressor cells (MDSCs) facilitate maternal-fetal tolerance in mice. J. Leukoc. Biol. 101 (5), 1091–1101. https://doi.org/10.1189/jlb.4HI1116-480R

Article  CAS  PubMed  Google Scholar 

Atretkhany K.S.N., Drutskaya M.S. 2016. Myeloid-derived suppressor cells and proinflammatory cytokines as targets for cancer therapy. Biochemistry (Moscow). 81, 1274–1283. https://doi.org/10.1134/S0006297916110037

Article  CAS  PubMed  Google Scholar 

Bronte V., Brandau S., Chen S.H., Colombo M.P., Frey A.B., Greten T.F., Mandruzzato S., Murray P.J., Ochoa A., Ostrand-Rosenberg S., Rodriguez P.C., Sica A., Umansky V., Vonderheide R.H., Gabrilovich D.I. 2016. Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. Nat. Commun. 7, 12150. https://doi.org/10.1038/ncomms12150

Article  CAS  PubMed  Google Scholar 

Solito S., Pinton L., De Sanctis F., Ugel S., Bronte V., Mandruzzato S., Marigo I. 2019. Methods to measure MDSC immune suppressive activity in vitro and in vivo. Curr. Protoc. Immunol. 124 (1), e61. https://doi.org/10.1002/cpim.61

Article  CAS  PubMed  Google Scholar 

Tatarinov Y.S., Masyukevich V.N. 1970. Immunological identification of a new beta L-globulin in the blood serum of pregnant women. Bull. Exp. Biol. Med. 69, 66–68. https://doi.org/10.1007/BF00802610

Article  CAS  Google Scholar 

Bohn H. 1971. Detection and characterization of pregnancy proteins in the human placenta and their quantitative immunochemical determination in sera from pregnant women. Arch. Gynecol. Obstet. 210, 440–457. https://doi.org/10.1007/BF02111961

Article  CAS  Google Scholar 

Hertz J.B., Schultz-Larsen P. 1983. Human placental lactogen, pregnancy-specific beta-1-glycoprotein and alpha-fetoprotein in serum in threatened abortion. Int. J. Gynaecol. Obstet. 21 (2), 111–117. https://doi.org/10.1016/0020-7292(83)90080-7

Article  CAS  PubMed  Google Scholar 

Raev M.B. 2009. Method for isolating and purifying trophoblastic beta-1-glycoprotein. Russian Federation Patent No. 2367449.

Timganova V.P., Zamorina S.A., Litvinova L.S. et al. 2020. The effects of human pregnancy-specific β1-glycoprotein preparation on Th17 polarization of CD4+ cells and their cytokine profile. BMC Immunol. 21, 56. https://doi.org/10.1186/s12865-020-00375-7

Article  CAS  PubMed  Google Scholar 

Noman M.Z., Desantis G., Janji B., Hasmim M., Karray S., Dessen P., Bronte V., Chouaib S. 2014. PD-L1 is a novel direct target of Hif-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation. J. Exp. Med. 211 (5), 781–790. https://doi.org/10.1084/jem.20131914

Article  CAS  PubMed  Google Scholar 

Timganova V.P., Shardina K.Yu., Gutina E.V. 2023. The effect of Pregnancy Specific Glycoprotein on the expression of arginase-1 and indoleamine-2,3-dioxygenase by myeloid-derived suppressor cells. Ros. Immunol. Zhurnal. (Rus.). 26 (3), 403–408.

Google Scholar 

Ohta A., Gorelik E., Prasad S.J. et al. 2006. An adenosine receptor protects tumors from antitumor T cells. Proc. Natl. Acad. Sci. USA. 103 (35), 13 132–13 137. https://doi.org/10.1073/pnas.0605251103

Article  CAS  Google Scholar 

Allard B., Longhi M.S., Robson S.C., Stagg J. 2017. The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets. Immunol. Rev. 276 (1), 121–144. https://doi.org/10.1111/imr.12528

Article  CAS  PubMed  Google Scholar 

Hao Z., Li R., Wang Y. et al. 2021. Landscape of myeloid-derived suppressor cell in tumor immunotherapy. Biomark. Res. 9, 77. https://doi.org/10.1186/s40364-021-00321-6

Article  PubMed  Google Scholar 

Yang Y., Li C., Liu T., Dai X., Bazhin A.V. 2020. Myeloid-derived suppressor cells in tumors: From mechanisms to antigen specificity and microenvironmental regulation. Front. Immunol. 11, 1371. https://doi.org/10.3389/fimmu.2020.01371

Article  CAS  PubMed  Google Scholar 

Xue Q., Yan Y., Zhang R., Xiong H. 2018. Regulation of INOS on immune cells and its role in diseases. Int. J. Mol. Sci. 19 (12), 3805. https://doi.org/10.3390/ijms19123805

Article  CAS  PubMed  Google Scholar 

Markowitz J., Wang J., Vangundy Z., You J., Yildiz V., Yu L., Foote I.P., Branson O.E., Stiff A.R., Brooks T.R., Biesiadecki B., Olencki T., Tridandapani S., Freitas M.A., Papenfuss T., Phelps M.A., Carson W.E. 2017. Nitric oxide mediated inhibition of antigen presentation from DCS to CD4+ T cells in cancer and measurement of STAT1 nitration. Sci. Rep. 7, 15424. https://doi.org/10.1038/s41598-017-15718-2

Article  PubMed  Google Scholar